PaxMedica, Inc. (PXMD)
OTCMKTS · Delayed Price · Currency is USD
0.0005
0.00 (0.00%)
May 4, 2026, 4:00 PM EST
PaxMedica Employees
As of December 31, 2023, PaxMedica had 7 total employees, including 6 full-time and 1 part-time employees. The number of employees increased by 2 or 40.00% compared to the previous year.
Employees
7
Change (1Y)
2
Growth (1Y)
40.00%
Revenue / Employee
n/a
Profits / Employee
-$1,926,868
Market Cap
63.14K
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2023 | 7 | 2 | 40.00% | 6 | 1 |
| Dec 31, 2022 | 5 | 1 | 25.00% | 3 | 2 |
| Jun 30, 2022 | 5 | -1 | -16.67% | 2 | 3 |
| Mar 31, 2022 | 4 | -2 | -33.33% | 2 | 2 |
| Dec 31, 2021 | 4 | -2 | -33.33% | 2 | 2 |
| Sep 30, 2021 | 6 | 2 | 50.00% | 3 | 3 |
| Dec 31, 2020 | 6 | 2 | 50.00% | 3 | 3 |
| Jun 30, 2020 | 4 | - | - | 1 | 3 |
| Mar 31, 2020 | 4 | - | - | 1 | 3 |
Related Stocks
| Company Name | Employees |
|---|---|
| Scorpius Holdings | 91 |
| Synairgen | 34 |
| Vincerx Pharma | 13 |
| Panbela Therapeutics | 8 |
| Ocean Biomedical | 7 |
| LadRx | 2 |
| GB Sciences | 2 |
PaxMedica News
- 1 year ago - PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - Accesswire
- 1 year ago - PaxMedica Secures Immediate Exercise of Warrants - Accesswire
- 1 year ago - PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - Accesswire
- 2 years ago - PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - GlobeNewsWire
- 2 years ago - PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - GlobeNewsWire
- 2 years ago - PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - GlobeNewsWire
- 2 years ago - Why is PaxMedica (PXMD) stock surging today? - Invezz
- 2 years ago - PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission - GlobeNewsWire